Case report of canine co-infection with Leishmania infantum and Ehrlichia canis by Stefanovska Jovana et al.
19
UDC: 636.7.09:[616.98:579.881.3.083.3
              636.7.09:616.993.161]:616-097
  
Case Report
ABSTRACT
INTRODUCTION
Leishmaniasis in dogs is a serious protozoan 
zoonosis that infects millions worldwide. Dogs and 
human get infected by leishmania promastigotes 
induced by bite of infected sand ﬂ  y Phlebotomus 
spp.  Promastigotes multiply into the macrophages 
as intracellular amastigotes. Clinical signs may 
appear months or years after the infection (10). 
Visceral leishmaniasis or Kala-azar is a life-
threatening disease that has medical, social and 
economic importance in the endemic areas. Dogs 
are the main reservoir for Leishmania infantum. 
The clinical ﬁ   ndings are very different which 
impedes the diagnosis. Some dogs show clinical 
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signs while others remain asymptomatic carriers 
and are infective for sand ﬂ  y. There is no breed or 
age predisposition, although infection hasn’t been 
found in dogs younger than 5 months. Infected 
animals are usually affected with lymphadenopathy, 
anemia, desquamated and ulcerative skin lesions 
and glomerulonephritis with proteinuria. Ocular 
lesions like blepharitis, uveitis, corneal edema or 
chorioretinitis  may also be present. Unspeciﬁ  c 
symptoms may appear often, which makes the 
disease hard to diagnose (1). Renal lesions are often 
present in dogs with leishmaniasis. Membrane-
proliferative glomerulonephritis appears because 
of circulating immune complex deposit, which 
leads to proteinuria. These lesions may progress 
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to chronic renal failure or nephritic syndrome. 
Renal insufﬁ   ciency is one of the classic general 
symptoms that follow leishmaniasis, but are rarely 
the only manifestation of the disease (1; 4). Due to 
the capacity of the kidneys it is estimated that over 
75% of the tissue should be destroyed before the 
appearance of serum creatinine and urea elevations 
(12).
Canine monocytic ehrlichiosis (CME) is a 
diseases in dogs caused by rickettsia Ehrlichia 
canis.  Rhipicephalus sanguineus, known as a brown 
dog tick, traditionally found in southern Europe 
represent a main vector of the canine ehrlichiosis. 
(17). When the infected tick ingests a blood meal, 
the infective agent is inoculated on the feeding 
site through the salivary secretions. The course 
of ehrlichiosis in infected dog can be divided into 
three phases: acute, subclinical and chronic (18). In 
all three phases a wide variety of clinical signs can 
be manifested in dogs (6 ). It is proven by Schouls, 
L.M. et al. (1999) that the same tick species can 
be a vector for several pathogens and co-infection 
with different infectious agent by individual ticks 
can occur. The common clinical signs between 
leishmaniasis and ehrlichiosis that can mislead to a 
correct diagnosis are : weakness, lethargy, anorexia, 
chronic weight loss, epistaxis, fever, pale mucous 
membranes, enlarged lymph nodes, splenomegaly, 
ocular signs. Furtheremore L. infantum kDNA in 
salivary glands of R. sanguineus ticks has been 
reported (3). Hence, it is very crucial to run several 
diagnostic test for detection of different pathogens 
and perform detailed laboratory analyses before 
deﬁ  ning  the  ﬁ   nal diagnosis, especially in cases 
where ticks were registered on dogs.
MATERIALS AND METHODS
 
Case history
Our patient was a dog, 11 year old Samoyed, 
weighing 25kg.The origin of the dog was from town 
Stip in East part of R. Macedonia, historically known 
as  Kala azar district.  The dog has been kept in yard 
and it was in a good body condition. Prior diseases 
connected with parasitic infections were not present. 
The owner gave  information about occasional 
appearance of heavy nose bleeding (epistaxis). Any 
other clinical signs were not noticed. The dog was 
never protected with any repellent during the season 
of insects. 
Clinical observation and diagnosis
 First physical examination revealed normal 
temperature, respiration and pulse and good quality 
of the coat. Submandibular and popliteal lymph 
nodes were enlarged with normal temperature and 
no pain. The clinical signs and medical history didn’t 
give enough information for diagnosis, so additional 
examinations were made, such as  hematological 
and biochemical analyses. Based on a single 
clinical symptom epystaxis a doubt was placed 
for L. infantum and Ehrlichia canis, hence a few 
diagnostic methods were performed. Serum sample 
was tested for Leishmania-speciﬁ  c  antibodies 
by an indirect ﬂ   uorescent-antibody test (IFAT) 
according to recommendation from OIE (5) (Figure 
1). Samples showing ﬂ   uorescence with serum 
dilutions equal or higher than 1:80 were regarded as 
positive. Antibody detection against CanL was also 
performed using an indirect ELISA (INGENASA). 
For the detection of E. canis antibodies a commercial 
ELISA kit (SNAP® 4Dx®; IDEXX Laboratories, Inc. 
U.S.A.), was performed twice, after the ﬁ  rst clinical 
examination and 6 months after. Both ELISA test 
were performed according to the manufacturer’s 
instruction listed in the product package insert. 
Figure 1. Leishmania-speciﬁ  c antibodies by an indirect 
ﬂ  uorescent-antibody test (IFAT)
Treatment
Most common therapy approach in dogs diagnose 
with CanL is using pentavalent antimonials. 
Besides the reduction of the parasites they create 
resistance, so a parallel treatment with allopurinol 
is necessary to prevent relapse (9). Allopurinol 
is an oral medication (hypoxanthine) which is 
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metabolized by the parasites of leishmania and 
produces inactive analog inosine that incorporates 
into parasite’s RNA and produces false protein 
synthesis. It is used in dogs independently or in 
combination with pentavalent antimonials, because 
of its limited toxicity, efﬁ  ciency and low price (2). 
The most common doses are 10-30 mg/kg daily, 
divided in two doses every 12 hours, in a long 
period of time. Side effects are rare. Some of the 
combined therapeutic protocols are given in Table 1. 
Due to the availability of medications, Allopurinol 
(Zyloprim; GSK, 100mg) therapy (20 mg/kg, p/o 
9-12 months) was chosen, with recommendation for 
controls every 3 months.  
Table 1. Recommended therapy protocols
Medicine Doses and applications Duration of therapy
Alopurinol 10-30 mg 2x24  p/o 9-12 months
Amfotericin B 0,5-0,8 mg/kg
2 x per week
Total dose 6-12 mg/kg
creatinin controle once a week.
Meglumin antimonat +
Alopurinol
50 mg/kg; 
10-30 mg 2x24  p/o
20-40 days 
 9-12months
Amfotericin B+
Alopurinol
0,5-0,8 mg/kg; 10-30 mg 2x24   
p/o
9-12 months creatinin control
RESULTS
The haematological and biochemical results 
after the ﬁ  rst clinical examination given in the Table 
2 and 3 revealed only light leucocitosis. All other 
results were normal.
Table 2. Hematology analysis 
Parameter Reference Result
WBC 6 – 17 * 109/L 17,7
RBC 5,5 – 8,5 * 1012g/l 6,75
Hgb 12 – 18 *10g/l 13,2
PCV 37 – 55 % 34,2
MCV 60 – 77 ﬂ  51,4
MCH 19,5 – 24,5 pg 19,6
MCHC 32 – 36 g/dl 38
Platelets 2 – 9 *1011/l 3,6
Mac. Vet. Rev. Vol 34, No. 1, 19 - 24, 201122
Table 3.  Biochemical analysis 
Biochemical analysis
Parameter Unit Reference Result
ALT U/l 8,02-57,3 15
GGT U/l 1,0-9,7 3
AST U/l 8,9 – 48,5 29,1
Creatinine μmol/L 44,3-138,4 106,7
Urea mmol /L 3,1-9,2 7,9
Glucose mmol /L 3,4-6,0 3.96
Total protein g/L 55,0-75,0 62,3
Albumins g/L 26,0-40,0 27,4
BUN
(blood urea nitrogen)
mmol/L 0-0.12 0.02
Ca mmol /L 2,2 - 3 1,3
Phosphates mmol /L 1 - 2 1,19
Case monitoring
 Because of the distance, the owner wasn’t able 
to bring the dog for controls. After 6 months, therapy 
was ended by the owners, without prior consultation. 
Week after the therapy was ended  weakness and 
reduced appetite were noticed. The symptoms after 
short period of time elevated to low coordination in 
space, probably blindness, incontinent urination and 
complete loss of appetite.  By our recommendation, 
the patient was delivered for further examinations. 
During the clinical examination weakness, 
dehydration, pale mucous membranes and uremic 
breath were noticed, pupilar reﬂ  ex was lost, eye balls 
were drawn into the orbit. Palpation of the lymph 
nodes revealed enlargement of the submandibular 
lymph nodes. Body temperature was 36, 6°C, the 
pulse was barely sensed, shallow breathing was 
registered. The patient was kept in the clinic’s 
stationary. Biochemical serum analyses were made 
and enormously elevated serum creatinin and urea, 
elevation of the total serum proteins and decreased 
albumins were noticed. These parameters, especially 
the levels of creatinin and urea indicated that the 
glomerular ﬁ  ltration was disturbed. Depression of 
serum albumins and increased activity of serum 
GGT, gave us indication of early stages of hepatic 
damage. Elevation of the total serum proteins 
indicates nephrotoxic condition in the organism. 
The results are given in table 4.
Table 4. Biochemical analysis 6 month after the initial examination 
Biochemical analysis
Parameter Units Reference Result
ALT U/l 8,02-57,3 54.0
GGT U/l 1,0-9,7 11.4
Creatinine μmol/L 44,3-138,4 673.5
Urea mmol /L 3,1-9,2 54.35
Glucose mmol /L 3,4-6,0 3.96
Total proteins g/L 55,0-75,0 106.4
Albumins g/L 26,0-40,0 21.4
BUN mmol/L 0-0.12 0.02
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Indirect immunoﬂuorescent-antibody test 
(IFAT) was regarded as positive since the titter of the 
examined serum was 1:320. The other serological 
method performed with ELISA test conﬁ  rm  the 
positivity for L.infantum, because it resulted with an 
optical density (0,525) higher than the cut off value.
The commercial ELISA test for detection of the 
presence of E. canis antibodies was negative after 
the ﬁ  rst clinical examination and positive after six 
months, respectively after  the second examination. 
Due to the poor general condition of the patient 
and owner’s approval human euthanasia with 
Dorminal 20% (200mg pentobarbital sodium, 
Alfasan Holland) was undertaken. 
DISCUSSION
Generally visceral leishmaniasis in dogs has 
similar symptoms to that in people including: 
irregular fever, pale mucous membranes and 
progressive weight loss to cachexia. Hypertrophy of 
the mononuclear-fagocitic systemis which is often 
present leads to splenomegalia, hepatomegalia 
and generalized adenopathy. The most common 
signs are related to skin lesions as local or diffuse 
lost of hair, isolate ulcerations of the snout and 
legs, dermatitis, as well as purulent conjunctivitis 
and keratitis, apathy, diarrhea and vomiting (15). 
According to the same authors no-regenerative 
anemia is an often ﬁ  nding. A.Blavier et al. (2001) 
found that membrane-proliferative glomerulo-
nephritis appears as consequence of the circulating 
immune-complex deposits, which later results in 
proteinuria. These lesions can progress to chronic 
renal insufﬁ   ciency or nephritic syndrome. Renal 
insufﬁ  ciency is one of the classic general symptoms 
that fallow leishmaniasis, bur rarely are the only 
manifestation of the disease (1). According to the 
research done by Soares, M.J.V. et al. (2005) it was 
noticed that the concentrations of serum creatinin 
and urea are elevated in 5, 88% from the examined 
dogs with leishmaniasis. In 61, 76% from the group 
and 17, 65% from the control group membrane-
proliferative glomerulo-nephritis was present. They 
concluded that kidneys are one of the ﬁ  rst organs 
impacted by the parasite, but due to absence of 
clinical signs these changes are revealed much later. 
This case of leishmaniasis was very atypical, since 
at the beginning of the appearance of the disease 
only one clinical symptom such as epistaxis was 
present. This clinical symptom is not present only in 
leishmaniosis, since platelet-related bleeding, such 
as petechiae and echymoses of the skin and mucous 
membranes and epistaxis are common ﬁ  ndings in 
erlihiosis (16). Also many clinical symptoms and 
laboratory ﬁ  ndings may be common for this two 
diseases. According to the latter ﬁ  ndings in our case, 
the major pathogenicity was in the kidneys. Similar 
case  of renal insufﬁ  ciency due to leishmanisasis was 
presented in a Pit bull dog in Brazil (7). Exceptions 
were additional signs of alopecia, hepatic and spleen 
enlargement. Popliteal and prescapular lymph nodes 
were enlarged, while in our case enlargement was 
noticed in the submandibular and popliteal lymph 
nodes. Since renal insufﬁ  ciency can also be one of 
the symptoms in canine erlichiosis, we considered 
that crucial role in progression of the disease might 
be the co-infection with erlichiosis, termination of 
the therapy, as well as the age of the dog. In dogs 
co-infection with vector born diseases occurs 
in endemic area and that could partially explain 
variations in clinical presentation, pathogenicity 
and response to therapy (17). In our case we could 
not estimate when the secondary infection with 
E.canis happened, hence it was hard to conclude 
what was the role of this agent on the fast relapse of 
the disease, neither it’s role in pathological ﬁ  ndings 
of the kidneys. Discontinuation of the therapy 
with Allopurinol undoubtedly had a major impact 
on the course of the disease.  Allopurinol can be 
discontinued only when the  presence of complete 
physical and clinicopathological recovery will be 
evaluated by a thorough physical examination, 
complete blood count, full biochemistry panel and 
urinalysis. A marked decrease of antibody levels (to 
negative or borderline by a quantitative serological 
assay) should also be considered (8).  Based on 
pervious investigations, leishmaniasis is a disease 
which is hard to diagnose in time because of the 
long asymptomatic period, unspeciﬁ  c clinical signs 
that can faulty lead  to other diseases. Treatment of 
the disease is very long and it can be challenging for 
the owners of the dog, so they have to be prepared 
for what follows. It is important to mention the fast 
relapse of the disease in case of early termination 
or impropriate application of the therapy protocol. 
In conclusion, the present case study shows that 
dogs in R. Macedonia can be infected with more 
than one vector-borne pathogens, some of which 
can be zoonosis. Co-infections can be hard for 
diagnosis and consequently might lead to more 
severe clinical symptoms and pathogenicity. 
Therefore , prophylactic measures, such as the use 
of ectoparasiticides against insects, must be put in 
place in order to protect dogs and limit the risk of 
zoonotic potential.
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